Navigation Links
Pediatricians Split on Heart Tests Before Kids' ADHD Meds
Date:1/16/2012

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Jan. 16 (HealthDay News) -- Some pediatricians continue to do electrocardiograms (EKGs) on children before starting them on medication for attention-deficit hyperactivity disorder, new research suggests, even though many experts say the latest evidence shows it isn't really necessary.

Several years ago, reports of sudden death, heart attack and stroke among children and adults taking stimulants to treat ADHD caused alarm among parents and health care providers about the safety of the medications.

The reports prompted Canadian health authorities to briefly pull Adderall from the market in 2005, while the U.S. Food and Drug Administration now requires that ADHD drugs carry a "black box" label warning about potential heart risks.

Further research suggested that the risk may only be to children who had underlying heart defects, such as some congenital abnormalities and arrhythmias. On Adderall, for example, the warnings now read: "Sudden death has been reported in association with CNS [central nervous system] stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems."

A few years ago, the American Heart Association stated that it would be "reasonable" to give kids EKGs, which look for abnormalities in the heart's electrical activity, before starting them on stimulant medication.

But in 2008, the American Academy of Pediatrics (AAP) issued a policy statement saying that routine EKGs prior to starting kids on ADHD medications wasn't necessary.

"A lot of pediatricians started doing EKGs, and then when the AAP said it didn't agree with that, pediatricians scaled back," explained Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Steven & Alexandra Cohen Children's Medical Center of New York.

And two major recent studies have found no hearts risk associated with ADHD medications. In a study published last November in the New England Journal of Medicine, researchers concluded that medications such as Ritalin, Adderall and Concerta don't raise the risk of sudden death, heart attack or stroke in children and young adults.

In the study, researchers from Vanderbilt University and colleagues analyzed data on 1.2 million children and young adults aged 2 to 24 enrolled in four large health plans around the United States.

And a study published last December in the Journal of the American Medical Association analyzed data on more than 150,000 young and middle-aged adults taking one of several ADHD drugs and found no added risk of heart attack, sudden cardiac death or stroke, even among people with a family history of heart disease.

"The recent data suggests there is no increase in sudden cardiac death or any need for cardiac monitoring, provided there is no history of heart disease in the patient and no family history of heart disease," said Dr. Victor Fornari, a professor of psychiatry at Hofstra North Shore-LIJ School of Medicine, in New York.

The current research, published in the February issue of Pediatrics, surveyed 525 U.S. pediatricians about their ADHD prescribing practices.

The vast majority of physicians said they did a routine medical history and physical before putting kids on stimulants to treat ADHD.

Less than half (48 percent) did a more in-depth cardiac history and physical, which is recommended by the AAP.

About 15 percent also ordered an EKG to look for abnormal heart rhythms. The most common reason for continuing to do EKGs was that it was the "prevailing practice" where they worked.

"Pediatricians have a very variable attitude toward the safety and efficacy of these medications," Fornari said. "Even though there is no evidence base to suggest continued cardiac screening, there persists this lingering attitude among physicians that 'I'm not comfortable unless I do it'."

And even many children with underlying heart issues are safely taking ADHD medications, Adesman said.

"Most children with underlying heart problems are likely still eligible to be treated with stimulants once the family, the pediatrician and a consulting pediatric cardiologist agree that it's justifiable and safe," Adesman said.

He added: "There are only a few very specific, relatively uncommon cardiac problems where one would be hesitant to use a stimulant."

The survey also found nearly half (46 percent) of pediatricians said they also discussed stimulant-related heart risks with parents. In most situations, making sure families are fully informed of any risks is good practice, Fornari said. But given how little evidence there is that ADHD medications pose heart risks to children, in this situation those conversations may be causing unnecessary worry and deterring some families from trying stimulants.

Almost 3 million children in the United States take prescription medications for ADHD each year. Children with the neurobehavioral disorder have excessive levels of activity, inattention and impulsiveness.

More information:

The U.S. National Institute of Mental Health has more on ADHD.

SOURCES: Andrew Adesman, M.D., chief, developmental and behavioral pediatrics, Steven & Alexandra Cohen Children's Medical Center of New York, New Hyde Park, N.Y.; Victor Fornari, M.D., professor, psychiatry, Hofstra North Shore-LIJ School of Medicine, New York; February 2012 Pediatrics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Memo to pediatricians: Allergy tests are no magic bullets for diagnosis
2. Pediatricians Offer Tips to Avoid Holiday Hazards
3. Washington pediatricians receive regular requests for alternative child immunization schedules
4. Caroll Spinney, AKA Big Bird to address Nations Pediatricians
5. BMC pediatricians find increase in SNAP benefits associated with healthier children
6. Pediatricians in Appalachia less likely to recommend HPV vaccine
7. Many Pediatricians Arent Testing Tots for Developmental Delays
8. Pediatricians Group Raps Energy and Sports Drinks for Kids
9. Pediatricians Urge Better Protection From Chemicals
10. UT Southwestern pediatricians launch landmark childrens health study
11. Pediatricians Group Backs Ban on Tanning Booth Use by Minors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pediatricians Split on Heart Tests Before Kids' ADHD Meds
(Date:2/8/2016)... ... 2016 , ... FileHold's document management software has been implemented ... hosted environment for FileHold software that is pay per user subscription-based and also ... the FileHold web services API. DocuSyst also advises clients on fully functioning back ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... are derived from a cluster of melanin when exposed to sunlight. Although most moles ... a lifetime of embarrassment. Historically, mole removal has involved a painful, often ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... (NADL), only four states in the U.S. require dental technicians to be certified ... in the dental industry, NADL created the “What’s In Your Mouth?” campaign to ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds and ... launch of a new DRTV campaign with Belly Bands. , Having a dog is ... sprays to puppy pads and find nothing works, get Belly Bands, the easiest ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  As people age, ... The multitude of recommended screenings and tests that are ... a priority. However, for the majority of aging individuals, ... health planning. For the 37.5 million American adults who ... the present to make hearing health a 2016 healthy ...
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ("Aralez") ... POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") following ... shareholders of Tribute. The combined company will operate under ... with operations in Canada , ... States . Under the terms of the Agreement ...
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... Chairman and CEO, will be presenting at Source Capital Group,s ... York, NY at 2:15 p.m. ET on Wednesday, ... Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... approximately one hour after the conclusion of the live event. ...
Breaking Medicine Technology: